ImmunityBio, Inc. IBRX

I can't buy anymore so I have done my part 550,000 shares my brother from the marines my little brother and best friend on the planet has 1 million and he runs his families trust and it has 1 million shares we are tapped out....

When we have 100% approval for bladder hang on. Next will be lung, Lymphopenia, lymphoma and at some point for nearly every cancer like Merck's Keytruda and Keytruda sales will fall off the cliff. Why Anktiva works infinitely better.

What would Paul Silberberg say MAYBE

Nothing has changed, the story remains the same.....So buy buy buy and hold don't trade this stock or you risk being out the day it doubles on news.

Paul Silberberg thoughts please

Jamesy get off the board and go away why are you posting ?

ImmunityBio can produce all of the Anktiva need plus BCG too. This was required before approval remember.

Lance very logical I believe ImmunityBio is profitable 1st Q next year maybe before

Saudi is going to be the cancer treatment destination for all of the Middle East and the wealthy of the world.

I have a neighbor mid 50s fighting astrocytoma and he needs Anktiva or he will die my bet next 6-12 months.

If Anktiva works for gleoblastoma it will work for astrocytoma too........

I agree that a mRNA flu jag is not needed and a really bad idea.

Danial ? no one is listening to you paid short ass holes ??????